Navigation Links
Pharmacyclics Reports Updated Clinical Results from its Phase IA Trial of its First in Human Btk-Inhibitor PCI-32765
Date:12/7/2010

molecule inhibitor of Bruton's tyrosine kinase (Btk) that is being developed by Pharmacyclics for the treatment of patients with B-cell lymphoma or leukemia. Btk plays a prominent role in B-cell lymphocyte maturation by mediating B-cell receptor (BCR) signal transduction. Recent studies indicate that some B-cell lymphomas have kinases that are activated downstream of the BCR and that suppression of this signaling by a Btk inhibitor can induce apoptosis in these cells. BCR signaling is also thought to promote malignant cell expansion and survival in chronic lymphocytic leukemia (CLL).

About Non-Hodgkin's Lymphoma  Non-Hodgkin's lymphoma (NHL) is a type of malignant disease that occurs within the lymphatic system and the fifth most common form of cancer. It is caused by the abnormal proliferation of white blood cells, which spreads through the lymphatic system.  NHL can occur at any age and is often marked by lymph nodes that are larger than normal, fever, and weight loss. NHL can be broadly classified into two main clinical categories: indolent lymphomas, mainly characterized as follicular lymphomas, which tend to grow relatively slowly; and aggressive lymphomas, mainly typified as diffuse large B-cell lymphomas (DLBCL), which grow much more rapidly. According to the National Cancer Institute's SEER database the incidence of NHL (all types including indolent and aggressive) is projected at nearly 66,000 in the United States for 2009 and approximately 19,500 patients are expected to die from this disease. According to the Leukemia & Lymphoma Society (LLS), there are approximately 452,723 people in the United States living with NHL (with active disease or in remission).

About PharmacyclicsPharmacyclics® is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. Our mission and goal is to build a viable biopha
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
2. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
3. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
4. Pharmacyclics Novel Factor VIIa Inhibitor Demonstrates Potential Inhibition of Tumor Growth in Multiple Types of Cancer
5. Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma
6. Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483
7. Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.
8. Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkins Lymphoma
9. Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier
10. Pharmacyclics to Present at Merriman Curhan Fords Investor Summit 2009
11. Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st Annual Meeting of the American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... MENLO PARK, Calif. , June ... (OTCQX: DMPI) ("DelMar" and the "Company"), a ... cancer therapies in new orphan drug indications, today ... clinical trial of  VAL-083  (dianhydrogalactitol) in patients with ... deadly form of human brain cancer. ...
(Date:6/1/2015)... SAN DIEGO , June 1, 2015  Diomics, ... Richard M. Weissman , global financial executive, has ... Mr. Weissman has more than 25 years of industry ... Diomics, he served as a managing director at Credit ... UBS and Morgan Stanley/Dean Witter. "Diomics is ...
(Date:6/1/2015)... 1, 2015  AbbVie (NYSE: ABBV ) will ... June 4, 2015. Richard A. Gonzalez , chairman ... and answer session at 8:30 a.m. Central time. ... be accessible through AbbVie,s Investor Relations Web site at ... will be available later that day. ...
Breaking Medicine Technology:DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 2DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 3DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 4DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 5DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 6DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 7DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 8Richard M. Weissman joins Diomics Board of Directors 2
... SuccessEHS, a nationally recognized, streamlined practice management and ... ambulatory care software solution with a signature Success Architecture ... With this pairing, SuccessEHS is well-positioned to meet ... The essential technical, functional and reporting needs of a ...
... 21, 2011 Sheffield Bio-Science, a Kerry Group Business, ... alliance with Wockhardt Ltd. Under this partnership, Sheffield Bio-Science ... for recombinant insulin manufactured by global Indian biotech Wockhardt. ... is around US$ 50 million. Speaking on ...
Cached Medicine Technology:SuccessEHS Announces its Enterprise Ambulatory EHR Solution for Hospitals 2SuccessEHS Announces its Enterprise Ambulatory EHR Solution for Hospitals 3SuccessEHS Announces its Enterprise Ambulatory EHR Solution for Hospitals 4Sheffield Bio-Science and Wockhardt Announce Worldwide Exclusive Partnership to Supply Recombinant Insulin to Cell Culture Market 2
(Date:6/1/2015)... Listen to Volvo’s Director of Connectivity ... using more granular data to create better customer oriented ... voices in Josep Celaya Gonzalez, CIO at MAPFRE, and ... an automotive insurer, MAPFRE are well versed in capturing ... to the driver. Award winning start-up ParkTAG offer an ...
(Date:6/1/2015)... Norcross, GA. (PRWEB) June 01, 2015 ... Producer Online, which is a new cloud-based subscription service ... sensing and GIS software. , Both ERDAS IMAGINE ... online access through Producer Online, which offers a subscription ... , “Today’s organizations need to be able to quickly ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 The session, ... include Artur Seidel, vice president of Elektrobit Automotive ... consultant John Ellis; it will be moderated by Andy ... the growing importance and complexity of in-vehicle software in ... issues of security and how the wider ecosystem can ...
(Date:6/1/2015)... This is the final call for registration ... of Local Food, June 11 - 13 at The ... cities in examining and developing solutions to strengthen their ... for the city of Riverside by Seedstock co-founder Robert ... speakers ranging from urban agriculture entrepreneurs, USDA representatives from ...
(Date:6/1/2015)... If you dread visiting a dentist because of ... some encouraging news. With an idea created by two ... Marcos, Calif., you no longer need to worry. , ... to provide improved oral suction needed for dental exams, ... dental patient’s throat more comfortable by removing excess fluids ...
Breaking Medicine News(10 mins):Health News:Complimentary Webinar: Volvo, MAPFRE and Award Winning Start-Up discuss new Frontier of In-Car Services 2Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 2Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 3Health News:Elektrobit Automotive, Ford and Delphi to Tackle In-Vehicle Software at TU-Automotive Detroit 2015 2Health News:Elektrobit Automotive, Ford and Delphi to Tackle In-Vehicle Software at TU-Automotive Detroit 2015 3Health News:Limited Tickets Available for “GrowRIVERSIDE” Conference June 11 2Health News:All-in-One Dental Aspirator Invented by InventHelp® Clients (SDB-733) 2
... , 221.10.254.64 GALVESTON, Texas Hydrogen sulfide is a ... Sometimes called "swamp gas," this toxic substance is generally associated ... as odd as it may seem it also plays ... of diabetes, according to a new study from the University ...
... Reporter , TUESDAY, Aug. 2 (HealthDay News) -- Special bioengineered spinal ... least in rats, a new study shows. While trials in ... collagen, may one day help people with back pain caused by ... the more artificial replacement discs in use today. "These ...
... uses fruit flies to study the genetics of cancer has ... Marios Georgiou, lecturer in cell biology in the University,s School ... Establishment Award of 600,000. The award is given every year ... cancer scientists of the future. Cancer Research UK ...
... , MONDAY, Aug. 1 (HealthDay News) -- Four of ... for the diagnosis and treatment of chronic obstructive pulmonary ... the recommendations are based on more recent studies of ... are meant largely to emphasize how critical it is ...
... indicates cholesterol lowering drugs known as statins may help prevent ... stroke. The study is published in the August 2, 2011, ... the American Academy of Neurology. "Because the cause ... cholesterol-lowering drugs are often not used to prevent further strokes ...
... 1 (HealthDay News) -- Teens are much more likely to ... school in neighborhoods with many fast food restaurants and other ... compared 2007 data on junk food consumption by California teens ... such as fast food restaurants, convenience stores, dollar stores and ...
Cached Medicine News:Health News:Scientists show 'swamp gas' protects blood vessels from complications of diabetes 2Health News:Bio-Engineered Spinal Discs Appear Successful in Rats 2Health News:Bio-Engineered Spinal Discs Appear Successful in Rats 3Health News:Nottingham scientist wins major cancer research award 2Health News:Nottingham scientist wins major cancer research award 3Health News:New Guidelines for Spotting, Treating COPD Released 2Health News:Cholesterol-lowering drugs may help prevent recurrent strokes in younger people 2Health News:With Junk Food Stores Nearby, Teens May Eat More of It 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: